A leader with 15 years big pharma experience and 5 years capital markets experience.
Experienced in operational and marketing roles at Pfizer Inc, Novartis and Zoetis.
A successful track record of product development, registration & product marketing launches, including commercialisation of numerous market leading blockbuster medicines.
Specialising in M&A, building high performance teams and cultures, corporate development and legal. She also completed the Pfizer Inc, 1-year internal leadership program in 2012.
Ms Phoenix has served on the Myopharm Board of Directors for 4 years and invested in almost all capital raises to date, while focussing on expanding Myopharm's clinical and commercial initiatives.